← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 30, 2019Last known activity
Jan 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 7 trials)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Recent trials (10)
- NCT06708741Sponsor investigatorPhase 3Jan 1, 2025
- NCT06708741Lead sponsorPhase 3Jan 1, 2025
- NCT06708741OfficialPhase 3Jan 1, 2025
- NCT05232734CollaboratorPhase 2Dec 1, 2022
- NCT05516628CollaboratorPhase 2Oct 31, 2022
- NCT05199324CollaboratorPhase 3Apr 1, 2022
- NCT05197088Lead sponsorPhase 3Jan 9, 2022
- NCT05197088Reponsible party - principal investigatorPhase 3Jan 9, 2022
- NCT04457726CollaboratorPhase 1/Phase 2Jul 1, 2020
- NCT06100367CollaboratorPhase 2/Phase 3Dec 30, 2019
Details
- Last known activity
- Jan 1, 2025